Steven Maron
MD
Medical Oncologist
👥Biography 个人简介
Steven Maron at MSK has contributed to understanding the molecular landscape of gastric cancer and to developing biomarker-driven treatment strategies, including research on Claudin 18.2 (CLDN18.2) as a therapeutic target now validated in clinical trials of zolbetuximab. His work on EBV-positive gastric cancer subtype biology and its extreme sensitivity to checkpoint inhibitors represents an important precision oncology application in gastric cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Steven Maron 的研究动态
Follow Steven Maron's research updates
留下邮箱，当我们发布与 Steven Maron（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment